Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial - Hezode, C; Asselah, T; Reddy, K R (Lancet (London, England), 2015)
et al.